Company: VRCA
Filing Date: 2025-04-22
Form Type: DEF 14A
Source: 0001193125-25-087838
Chunk: 61

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-04-22
Form: DEF 14A
Chunk 61
---
 the date of termination).

<div align='center'>47</div>

POLICIES AND PRACTICES RELATED TO THE GRANT OF CERTAIN EQUITY AWARDS From time to time, we grant stock options to our employees, including our named executive officers. Historically, we have granted new-hireoption awards on or soon after a new hire’s employment start date and annual refresh employee option grants in the first quarter of each fiscal year, which refresh grants are typically approved at the regularly scheduled meeting of the Compensation Committee occurring in such quarter. Also, non-employeedirectors receive automatic grants of initial and annual stock option awards, at the time of a director’s initial appointment or election to the board and at the time of each annual meeting of our stockholders, respectively, pursuant to our non-employeedirector compensation policy, as further described under the heading, “Non-EmployeeDirector Compensation—Narrative to Director Compensation Table” above. We do not otherwise maintain any written policies on the timing of awards of stock options, stock appreciation rights, or similar instruments with option-like features. The Compensation Committee considers whether there is any material nonpublic information about us when determining the timing of stock option grants and does not seek to time the award of stock options in relation to our public disclosure of material nonpublic information. We have not timed the release of material nonpublic information for the purpose of affecting the value of executive compensation. The following table is being provided pursuant to Item 402(x)(2) of Regulation S-K:

| Name                 |     | Grant Date |     |            |     | Number of Securities 
 Underlying the Award |     |           |     | Exercise  
 Price of  
 the Award 
 (s)       |     |        |     | Grant Date 
 Fair Value 
 of the     
 Award      
 ($)(1)     |     |           |     | Percentage Change in           
 the Closing Market Price       
 of the Securities              
 Underlying the Award           
 Between the Trading Day        
 Ending Immediately             
 Prior to the Disclosure of     
 Material Nonpublic             
 Information and the            
 Trading Day Beginning          
 Immediately Following          
 the Disclosure of              
 Material Nonpublic Information |     |            |
| Jayson Rieger        |     |            |     | 11/06/2024 |     |                      |     | 2,000,000 |     |           |     | 0.7463 |     |            |     | 1,187,744 |     |                                |     | -47.81%)(